Clearside Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. 

CEO
George M. Lasezkay
CEOGeorge M. Lasezkay
Employees
32
Employees32
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2011
Founded2011
Employees
32
Employees32

CLSD Key Statistics

Market cap
30.30M
Market cap30.30M
Price-Earnings ratio
-1.09
Price-Earnings ratio-1.09
Dividend yield
Dividend yield
Average volume
450.95K
Average volume450.95K
High today
$0.4099
High today$0.4099
Low today
$0.38
Low today$0.38
Open price
$0.40
Open price$0.40
Volume
177.22K
Volume177.22K
52 Week high
$1.65
52 Week high$1.65
52 Week low
$0.292
52 Week low$0.292

Analyst ratings

86%

of 7 ratings
Buy
14.3%
Hold
85.7%
Sell
0%

People also own

Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.